Dolby Laboratories, Inc.
US ˙ NYSE ˙ US25659T1079

SecurityDLB / Dolby Laboratories, Inc.
InstitutionInvesco Ltd.
Latest Disclosed Ownership246,895 shares
Latest Disclosed Value $ 14,828,514
Invesco Ltd. reports 106.37% increase in ownership of DLB / Dolby Laboratories, Inc.

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 246,895 shares of Dolby Laboratories, Inc. (US:DLB) valued at $14,828,514 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 119,635 shares of Dolby Laboratories, Inc.. This represents a change in shares of 106.37% during the quarter. The current value of the position is $13,342,206 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 246,895 127,260 106.37 14,829 93.02 0.0023
2026-02-19 2025-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 119,635 -5,743 -4.58 7,683 -15.33 0.0012
2025-11-13 2025-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 125,378 -2,344 -1.84 9,074 -4.33 0.0014
2025-08-13 2025-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 127,722 -4,320 -3.27 9,485 -10.56 0.0016
2025-05-12 2025-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 132,042 -134,227 -50.41 10,604 -49.01 0.0020
2025-02-13 2024-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 266,269 20,431 8.31 20,796 10.54 0.0038
2024-11-12 2024-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 245,838 11,093 4.73 18,814 1.16 0.0036
2024-08-13 2024-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 234,745 -4,886 -2.04 18,599 -7.35 0.0039
2024-05-14 2024-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 239,631 -85,082 -26.20 20,074 -28.27 0.0043
2024-02-13 2023-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 324,713 111,463 52.27 27,984 65.56 0.0067
2023-11-13 2023-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 213,250 58,783 38.06 16,902 30.77 0.0046
2023-08-11 2023-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 154,467 56,523 57.71 12,926 54.49 0.0034
2023-05-12 2023-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 97,944 -48,078 -32.93 8,366 -18.78 0.0023
2023-02-13 2022-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 146,022 51,964 55.25 10,300 68.08 0.0030
2022-11-14 2022-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 94,058 -844,089 -89.97 6,128 -90.87 0.0020
2022-08-15 2022-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 938,147 4,093 0.44 67,134 -8.11 0.0203
2022-05-16 2022-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 934,054 -30,309 -3.14 73,062 -20.44 0.0186
2022-02-14 2021-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 964,363 -154,771 -13.83 91,828 -6.76 0.0221
2021-11-15 2021-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 1,119,134 -1,297 -0.12 98,483 -10.57 0.0250
2021-08-17 2021-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 1,120,431 6,559 0.59 110,128 0.15 0.0271
2021-05-17 2021-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 1,113,872 215,116 23.93 109,962 25.96 0.0293
2021-02-16 2020-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 898,756 -163,633 -15.40 87,297 23.98 0.0254
2020-11-16 2020-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 1,062,389 190,042 21.79 70,415 22.54 0.0238
2020-08-14 2020-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 872,347 -4,629 -0.53 57,462 20.87 0.0205
2020-05-15 2020-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 876,976 -7,381 -0.83 47,541 -21.86 0.0200
2020-02-14 2019-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 884,357 451 0.05 60,844 6.49 0.0189
2019-11-14 2019-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 883,906 22,777 2.65 57,136 2.71 0.0149
2019-08-14 2019-06-30 13F/A-1 DOLBY LABORATORIES COM CL A 25659T107 861,129 805,420 1,445.76 55,629 1,485.78 0.0143
2019-08-14 2019-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 861,129 744,291 55,629
2019-05-15 2019-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 55,709 -21,261 -27.62 3,508 -26.30 0.0012
2019-02-14 2018-12-31 13F DOLBY LABORATORIES COM 25659T107 76,970 6,558 9.31 4,760 -3.39 0.0018
2018-11-14 2018-09-30 13F DOLBY LABORATORIES COM 25659T107 70,412 24,506 53.38 4,927 73.98 0.0016
2018-08-14 2018-06-30 13F DOLBY LABORATORIES COM 25659T107 45,906 4,923 12.01 2,832 8.71 0.0009
2018-05-15 2018-03-31 13F DOLBY LABORATORIES COM 25659T107 40,983 -5,001 -10.88 2,605 -8.63 0.0010
2018-02-14 2017-12-31 13F DOLBY LABORATORIES COM 25659T107 45,984 -7,011 -13.23 2,851 -6.46 0.0010
2017-11-14 2017-09-30 13F DOLBY LABORATORIES COM 25659T107 52,995 2,488 4.93 3,048 23.25 0.0011
2017-08-14 2017-06-30 13F DOLBY LABORATORIES COM 25659T107 50,507 2,297 4.76 2,473 -2.14 0.0008
2017-05-15 2017-03-31 13F DOLBY LABORATORIES COM 25659T107 48,210 -57,365 -54.34 2,527 -47.03 0.0008
2017-02-14 2016-12-31 13F DOLBY LABORATORIES COM 25659T107 105,575 -4,314 -3.93 4,771 -20.03 0.0016
2016-11-14 2016-09-30 13F DOLBY LABORATORIES COM 25659T107 109,889 29,197 36.18 5,966 54.52 0.0020
2016-08-15 2016-06-30 13F DOLBY LABORATORIES COM 25659T107 80,692 39,226 94.60 3,861 114.26 0.0014
2016-05-16 2016-03-31 13F DOLBY LABORATORIES COM 25659T107 41,466 -7,349 -15.05 1,802 9.68 0.0007
2016-02-16 2015-12-31 13F DOLBY LABORATORIES COM 25659T107 48,815 -335 -0.68 1,643 2.56 0.0007
2015-11-16 2015-09-30 13F DOLBY LABORATORIES COM 25659T107 49,150 2,640 5.68 1,602 -13.22 0.0007
2015-08-14 2015-06-30 13F DOLBY LABORATORIES INC-CL A COMMON 25659T107 46,510 7,904 20.47 1,846 25.32 0.0007
2015-05-15 2015-03-31 13F DOLBY LABORATORIES INC-CL A COMMON 25659T107 38,606 5,134 15.34 1,473 2.08 0.0006
2015-02-13 2014-12-31 13F DOLBY LABORATORIES INC-CL A COMMON 25659T107 33,472 -26,831 -44.49 1,443 -42.74 0.0006
2014-11-14 2014-09-30 13F DOLBY LABORATORIES INC-CL A COMMON 25659T107 60,303 -34,914 -36.67 2,520 -38.73 0.0010
2014-08-14 2014-06-30 13F DOLBY LABORATORIES INC-CL A COMMON 25659T107 95,217 65,019 215.31 4,113 206.03 0.0016
2014-05-15 2014-03-31 13F DOLBY LABORATORIES INC-CL A COMMON 25659T107 30,198 -63,906 -67.91 1,344 -62.95 0.0005
2014-02-13 2013-12-31 13F DOLBY LABORATORIES INC-CL A COMMON 25659T107 94,104 21,227 29.13 3,628 44.25 0.0014
2013-11-13 2013-09-30 13F DOLBY LABORATORIES INC-CL A COMMON 25659T107 72,877 26,359 56.66 2,515 61.63 0.0011
2013-08-14 2013-06-30 13F DOLBY LABORATORIES INC-CL A COMMON 25659T107 46,518 46,518 1,556 0.0007
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.